Pre-diabetes mellitus Dyslipidemia anti-hyperglycemia anti-dyslipidemia investigation
Conditions
Interventions
C. sinensis tea 1.5g/day for 12 weeks,P. indica tea 1.5g/day for 12 weeks,Placebo tea 1.5g/day for 12 weeks
Active Comparator Dietary Supplement,Experimental Dietary Supplement,Placebo Comparator No treatment
CST,PIT,Placebo group
Sponsors
Suranaree University of Technology
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Pre-diabetes age between 20 and 60 years. The pre-diabetes was diagnosed followed American Diabetes Association by Fasting Blood Sugar (FBS) 100 mg/dl (5.6 mmol/L) to 126 mg/dL (6.9 mmol/L) or Blood sugar 2h post-prandial 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) or HbA1c between 5.7-6.4% (39-47 mmol/mol)
Exclusion criteria
Exclusion criteria: (1) coronary heart diseases, e.g., heart failure, myocardial infarction, arrhythmia; (2) endocrine disease, e.g., sex gland disorder, thyroid disorder, and pituitary disorder; (3) pregnant or lactating women; (4) taking medications or supplements and herbs that might have interfered with blood glucose and lipid measurements. Participants were excluded if they had side effects of tea.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A single administration of tea on acute glucose tolerance 1 day Oral glucose tolerance testing | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid Profile 12 weeks after treatment TC, LDL-C, TG, HDL-C,Toxicity testing 12 weeks after treatment Blood toxicology (BUN, Creatinine, ALT, ALP, and CBC) | — |
Countries
Thailand
Contacts
Public ContactGriangsak Eumkeb
Suranaree University of Technology
Outcome results
None listed